ISSN 2321–3647
Sun, 19 Nov 2017

Safety and Efficacy of a Sofosbuvir Based Combination in Treatment of Egyptian Patients with Chronic Hepatitis C Genotype 4

Abdel-Hameed I.M. Ebid1, Mohammed Ahmed Mobarez1, Ramadan Ahmed Ramadan2

1. Department of Pharmacy Practice, Faculty of Pharmacy, Helwan University. Cairo, Egypt.

2.Internal Medicine, Hepatology Department, Ahmed Maher teaching Hospital, Cairo, Egypt.


Little is known about the safety and predictors of response of interferon (IFN), ribavirin (RBV), and sofosbuvir (SOF) combination in real-world settings. Hepatitis C virus (HCV) treatment decisions must depend on Real-world effectiveness data rather than clinical trails data., thus, the aim of this study is to comprehensively evaluate the safety and efficacy of this treatment in routine medical practice. A total of 105 treatment naïve patients with CHC genotype 4 with mean age 49 ± 7.26 years old of whom 62 were males and 43 were females, were treated with INF, RBV, and SOF for 12 weeks. Patients were monitored for safety and efficacy during the treatment and 12-week follow up periods. Seventy (66.67%) patients achieved a sustained virological response (SVR). The rate of SVR varied significantly by age, baseline fibrosis stage, aspartate aminotransferase (AST), alanine aminotransferase (ALT), serum creatinine (Scr), and hemoglobin (Hb). Most adverse effects were mild to moderate in severity and were well tolerated. The overall continuance rate without dose reduction was 80.95%. one patient discontinued treatment, due to neutropenia,. Hematologic toxicity included anemia with a frequency 19.05%. The efficacy of IFN/RBV/SOF combination for treatment of Egyptian CHC patients with genotype 4 in real-world setting was less than that reported in clinical trials.

Keywords: HCV, Interferon, Ribavirin, Sofosbuvir, SVR.

[PDF]  Viewed: 465  Downloaded: 94
  • Call for paper
    Call for paper

    American Journal of Pharmacy and Health Research (AJPHR) is a peer-reviewed, monthly official international journal allowing access to abstracts and full-text.

  • Email & SMS Alerts
    Email & SMS Alerts

    Email/SMS alert system is one of the key features and gives update information about the submitted manuscript.


  • Article Statastics
    Article Statastics

    American Journal of Pharmacy and Health Research (AJPHR) provides unique facility for authors to know popularity of articles on basis of numbers of PDF download and views. It will display in tabulated format.

  • Online Submission
    Online Submission

    American Journal of Pharmacy and Health Research (AJPHR) is one of the International open access journal devoted to various disciplines in science and technology.


web counter
web counter